MEDIUM confidence: 100% data completeness, but the composite (51) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $5.1B— | $5.5B+7.4% | $4.8B-13.0% | $4.2B-12.5% | $4.1B-2.2% |
| EPS (dil.) | $8.97— | $7.81-12.9% | $6.13-21.5% | $3.69-39.8% | $3.08-16.5% |
| Free Cash Flow | $1.1B— | $915M-18.3% | $1.6B+77.1% | $1.7B+2.9% | $1.1B-33.7% |
| Gross Margin | 49.2% | 47.5%-1.7pp | 44.2%-3.3pp | 41.2%-3.0pp | 41.2%-0.0pp |
| Operating Margin | 31.6% | 27.8%-3.7pp | 23.6%-4.3pp | 15.3%-8.3pp | 12.2%-3.0pp |
| Net Margin | 29.3% | 23.2%-6.1pp | 20.6%-2.7pp | 14.3%-6.3pp | 11.7%-2.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $68 (last qtr, 7 analysts) → $67 (last mo, 6) (-2.8%).
Buy-rated share 23% → 9% over ~3 months (-14pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.03 | $1.08 | +4.9% |
| May 2026 | $1.04 | $1.15 | +10.6% |
| Feb 2026 | $1.40 | $1.54 | +10.0% |
| Oct 2025 | $1.52 | $1.76 | +15.8% |
| Aug 2025 | $1.24 | $1.33 | +7.3% |
| May 2025 | $1.20 | $1.24 | +3.3% |
| Feb 2025 | $1.57 | $1.60 | +1.9% |
| Nov 2024 | $1.52 | $1.55 | +2.0% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
No recent open-market insider transactions.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 3.0%/yr (revenue basis).
Base free cash flow $1.5B (avg FY2023–FY2025; latest year $1.1B) · equity value $10.4B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 51 for SWKS indicates a neutral outlook, with the stock's scores driven up by its value and momentum factors, which score 57 and 59, respectively. However, its growth score of 37 weighs down the overall score, due to negative revenue and earnings growth. The stock trades at a premium, with a P/E of 35.7, but exhibits strong momentum, with a bullish 50-day versus 200-day moving average. The long-term and short-term scores are relatively aligned, with only a 3-point difference.